(Q34026108)

30 July 2017

1 reference

title

Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings--part II. (English)

1 reference

30 July 2017

0 references

0 references

Keshavan MS

1

1 reference

30 July 2017

Stanley JA

series ordinal

2

1 reference

30 July 2017

Pettegrew JW

series ordinal

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 September 2000

1 reference

30 July 2017

published in

Biological Psychiatry

1 reference

30 July 2017

volume

48

1 reference

30 July 2017

issue

5

1 reference

30 July 2017

page(s)

369-380

1 reference

A unitary model of schizophrenia: Bleuler's "fragmented phrene" as schizencephaly

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

A short echo proton magnetic resonance spectroscopy study of the left mesial-temporal lobe in first-onset schizophrenic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

The relationship between dorsolateral prefrontal N-acetylaspartate measures and striatal dopamine activity in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Common pattern of cortical pathology in childhood-onset and adult-onset schizophrenia as identified by proton magnetic resonance spectroscopic imaging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Quantitative proton-decoupled 31P MRS of the schizophrenic brain in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Human in vivo NMR spectroscopy in diagnostic medicine: clinical tool or research probe?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Frontal lobe of children with schizophrenia spectrum disorders: a proton magnetic resonance spectroscopic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Magnetic resonance spectroscopy in schizophrenia: a nascent technology for a neurodevelopmental disorder?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Effects of tumbling and lateral diffusion on phosphatidylcholine model membrane 31P-NMR lineshapes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

31Phosphorus magnetic resonance spectroscopy of the temporal lobes in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Hippocampal N-acetyl aspartate in unaffected siblings of patients with schizophrenia: a possible intermediate neurobiological phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Proton magnetic resonance spectroscopy in the frontal and temporal lobes of neuroleptic naive patients with schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

1H magnetic resonance spectroscopy characterization of neuronal dysfunction in drug-naive, chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Observation of metabolic changes in chronic schizophrenia after neuroleptic treatment by in vivo hydrogen magnetic resonance spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Basal ganglia phosphorous metabolism in chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

31phosphorus magnetic resonance spectroscopy of the frontal and parietal lobes in chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Correlation between left frontal phospholipids and Wisconsin Card Sort Test performance in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Decreased left frontal lobe N-acetylaspartate in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Hippocampal neuronal dysfunction in schizophrenia as measured by proton magnetic resonance spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Single-voxel proton magnetic resonance spectroscopy of the pons and cerebellum in patients with schizophrenia: a preliminary study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Study of chronic schizophrenics using 31P magnetic resonance chemical shift imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Proton magnetic resonance spectroscopy of basal ganglia in chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Haloperidol improves membrane phospholipid abnormalities in temporal lobes of schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Phosphorus magnetic resonance spectroscopy in schizophrenia: correlation between membrane phospholipid metabolism in the temporal lobe and positive symptoms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Proton magnetic resonance spectroscopy of the left medial temporal and frontal lobes in chronic schizophrenia: preliminary report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Regional proton magnetic resonance spectroscopy in schizophrenia and exploration of drug effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

The membrane hypothesis of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Lateralized abnormality of high-energy phosphate and bilateral reduction of phosphomonoester measured by phosphorus-31 magnetic resonance spectroscopy of the frontal lobes in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

In vivo neurochemistry of the brain in schizophrenia as revealed by magnetic resonance spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Development, disease and degeneration in schizophrenia: a unitary pathophysiological model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Magnetic resonance spectroscopy in psychiatry: potential, pitfalls, and promise

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Magnetic resonance imaging and spectroscopy in offspring at risk for schizophrenia: preliminary studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Phosphorus 31 Magnetic Resonance Spectroscopy Detects Altered Brain Metabolism Before Onset of Schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Biological correlates of slow wave sleep deficits in functional psychoses: 31P-magnetic resonance spectroscopy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

First-episode studies in schizophrenia: criteria and characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Heterogeneity of the psychoses: is there a neurodegenerative psychosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Schizophrenia and disordered neural circuitry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Alteration of brain phospholipid metabolites in cocaine-dependent polysubstance abusers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Hippocampal age-related changes in schizophrenia: a proton magnetic resonance spectroscopy study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Proton magnetic resonance spectroscopy: an in vivo method of estimating hippocampal neuronal depletion in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

MRI anatomy of schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Proton magnetic resonance spectroscopy (1H MRS) of the hippocampal formation in schizophrenia: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Initial investigation of the left temporoparietal region in schizophrenia by 31P magnetic resonance spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Correlation of phosphorus-31 magnetic resonance spectroscopy and morphologic findings in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

A 1H-decoupled 31P chemical shift imaging study of medicated schizophrenic patients and healthy controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Estimation of metabolite concentrations from localized in vivo proton NMR spectra

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Schizophrenia, the heteromodal association neocortex and development: potential for a neurogenetic approach.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

The reduced neuropil hypothesis: a circuit based model of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Proton magnetic resonance spectroscopy of the basal ganglia in patients with schizophrenia: a preliminary report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Nuclear magnetic resonance spectroscopy: new insights into the pathophysiology of mood disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings--part I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

An in vivo proton magnetic resonance spectroscopy study of schizophrenia patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Preliminary study of frontal lobe 1H MR spectroscopy in childhood-onset schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Decreased energy demanding processes in the frontal lobes of schizophrenics due to neuroleptics? A 31P-magneto-resonance spectroscopic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Implications of normal brain development for the pathogenesis of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

From neuropathology to neurodevelopment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

Proton magnetic resonance spectroscopy of the temporal lobes in schizophrenics and normal controls.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900940-9

10.1016/S0006-3223(00)00940-9

7 January 2021

Identifiers

DOI

1 reference

30 July 2017

1 reference